Kevzara — Cigna
Other Conditions (standard Inflammatory Conditions – Kevzara criteria)
Preferred products
- Actemra subcutaneous
- Tyenne subcutaneous
- Enbrel
- adalimumab-adbm
- Cyltezo
- adalimumab-adaz
- adalimumab-ryvk
- Simlandi
- Rinvoq
- Xeljanz tablets
- Xeljanz XR
- Rinvoq LQ
Initial criteria
- Patient meets the standard Inflammatory Conditions – Kevzara Prior Authorization Policy criteria
Reauthorization criteria
- Patient continuing therapy meets the standard Inflammatory Conditions – Kevzara Prior Authorization Policy criteria
Approval duration
1 year